Key Takeaways
- Recovery takes hold, margins jump: Revenue grew 13% YoY in domestic crop care and 38% YoY in seeds, while EBITDA margin expanded sharply as fixed-cost discipline and stable input prices kicked in.
- Exports are turning the corner: Global agrochemical inventory normalization and stabilizing generic prices drove B2B volume growth, though Acephate remains a drag in Brazil and the U.S.
- The seed business is delivering on its promise: A 38% revenue jump to INR305 crores, led by Diggaz North Cotton, validates the portfolio-reshaping strategy, even as maize and paddy faced supply constraints.
- Management is building for the long term, not optimizing quarters: Nine new crop protection products and 14 new seed products were launched, the sales force was reorganized, and digital tools like PlanGuru are being embedded, all while the CFO transitions out.
- What to watch next quarter: Whether early export purchases pull down Q2 revenue, how the monsoon-dependent pest and disease pressure shapes fungicide and insecticide demand, and any update on the new product pipeline’s revenue traction.
Demand Environment & Industry Recovery
- Global cycle turning: The agrochemical market is showing early signs of recovery after two years of degrowth since 2023, with inventory levels normalized and the sharp decline in generic product prices largely halted.
- Regional recovery is uneven: Latin America, APAC and Africa are stabilizing but recovering more slowly than other regions.
- India sentiment is supportive: An early and broadly favorable monsoon, high reservoir levels and supportive crop MSPs are lifting farmer sentiment, with relatively better crop prices for bajra, maize, oilseed, cotton and millets.
- Cotton sowing shift: Better price realization has driven a shift in cotton sowing patterns, aided by the spread of illegal RRBT cotton, though the issue persists; low carryover stocks open space for inventory replacement and possible modest price increases.
- Herbicide is the standout category: Herbicide is growing faster than other segments, driven by labor dynamics in the country.
- Trade inventory is satisfactory: Channel inventory is limited in cotton, so no major risk is seen, while rice and maize had some shortage due to processing challenges in April and May.
- The monsoon bet is still open: August and September are very important for pest watch; more visibility on liquidity will come by H1. Rainfall disparities exist, with Bihar and the Northeast receiving less rain.
Shukla: "The global agrochemical market is showing early sign of recovery after 2 challenging years of degrowth since 2023. Inventory levels have normalized and the sharp decline in prices, particularly for generic products has largely come to a halt."
Export Business & B2B Dynamics
- Volume-led recovery: B2B export growth came mainly from Metribuzin, Thiophanate-methyl, Metalaxyl and Hexaconazole, driven by a combination of market recovery, new customer additions and some early purchases.
- Early purchases create a Q2 headwind: Some early buying in exports may impact Q2 revenue, and management noted the prebuying or stocking mindset has gone away from customers.
- Acephate remains the problem child: Acephate continues to face challenges in Brazil and the U.S., and prices continue to be soft; the strategy is to add new products in those customer relationships and reduce reliance on acephate.
- Pendimethalin underutilized: The technical operated at low capacity, but management is confident on its long-term prospects.
- Pricing has stabilized: Year-on-year price erosion has been arrested, with some pockets seeing rates go up; price movements are very product-specific, with some improvement in Metribuzin prices while Hexaconazole and Pendimethalin prices have not moved much.
- Americas-led demand: Export growth is primarily from the Americas, with LatAm buying for the September/October planting season and the U.S. buying for seasonal needs.
- Tariff impact is net neutral: The tariff situation has been positive for some products and negative for others, but overall stable.
Shukla: "Acephate continues to face challenges in Brazil and U.S. Pendimethalin operated at a low capacity, but we are confident on the long-term prospects of the technical."
Seed Business Transformation
- Revenue surged 38% to INR305 crores: The jump came despite reduced cotton acreage driven by RRBT cotton expansion, with Diggaz North Cotton performing very well.
- Cotton is the anchor: Cotton is a large contributor to seed growth and will remain a significant contributor for the next two to three years; follow-on hybrids to Diggaz have been developed and are showing good improvement.
- Supply constraints hit maize and paddy: Challenges in maize and paddy arose from processing difficulties in April and May, and bajra availability was lower due to quality issues.
- Research rice is scaling: The category grew from approximately INR5 crores to approximately INR10 crores and is expected to grow further.
- Seedsay AI tool is live: The AI and ML-based forecasting tool is helping with optimal placement in the market.
- Margin profile is Q1-skewed: The Q1 seed EBITDA margin of approximately 26% is lopsided toward the first quarter; other quarters have less or no sale but costs persist, making the long-term seed EBITDA target 20%.
- Portfolio mix visibility after H1: The paddy and maize mix should become clearer after the first half.
Margins & Cost Structure
- Fixed-cost discipline drove the margin beat: Fixed costs are lower on a year-on-year basis, which is where margins improved far more than gross margin, and the company is ahead of internal targets.
- Gross margin declined approximately 200 bps vs historical trend: The positive factor was the high-margin seeds business; the negative was the B2B export business, which carries lower gross margin, and within seeds, cotton mix is lower margin compared to the overall portfolio.
- Management tracks gross contribution, not gross margin: The metric includes raw material, power and labor; management says gross contribution is on the right track.
- Scale-driven variable cost efficiency: When plants get fully utilized, efficiencies start coming in variable costs in terms of utility, power and contractual manpower.
- Employee cost is well maintained: Employee cost stayed disciplined despite revenue growth; investments in special and senior talent will continue, but the cost will not simply be Q1 multiplied by four.
- Long-term EBITDA margin target is 15% to 20%: The ambition is a 500 bps steady improvement from where the company was, with seed delivering 20% and crop protection at 15%, operating in a range depending on which business grows more in a given year.
- ROCE and ROE improvement path: Margin improvement, working capital kept under check through inventory rationalization and tail brand reduction, capex discipline and better capacity utilization will all drive an uptick in ROE.
Shukla: "Long term, what we have been saying is that we wanted to come to 500 basis point steady improvement from where we were, right? Now obviously, quarters and quarters will change. But directionally, we would like to operate in the range of 15% to 20% EBITDA margin over a period of time."
New Product Pipeline & Strategic Initiatives
- Nine crop protection products launched: Three herbicides (Allato, Penflor, Deweed), two fungicides (Dodrio for paddy sheath blight, Master Gold for grapes) and one insecticide (Fiplam for cotton) were named; the remaining three were not disclosed.
- Fourteen new seed products launched: The seed business introduced 14 new products this quarter.
- Portfolio gaps are being filled: The new launches fill gaps in the herbicide, fungicide and insecticide categories, with some products specific to rice and others applicable across multiple crops.
- Sales and marketing reorganization completed: The restructure covers Crop Care B2C, B2B and the seeds business, and is expected to enhance operational agility with revised business processes.
- PlanGuru digital tool is scaling: The SAP-based SKU-level forecasting tool is in its second to third year, now being used for portfolio segmentation and dynamic stock management after a trial first year.
- CSM business is progressing but opaque: Two key technicals are active, one in Japan and one in the U.S.; management declined to quantify the business, citing customer confidentiality, and noted it has not yet cracked a INR500 crore manufacturing opportunity.
- New global customer relationships are forming: Encouraging progress is being made in initiating new relations for some technical products and contract manufacturing, and the company is actively working on expanding formulation partnerships with international players.
Shukla: "I keep saying that we haven't still cracked a INR500 crore manufacturing opportunity yet."
Capital Allocation & Balance Sheet
- Working capital days have come down year-on-year: Measures are being taken on inventory rationalization and tail brand reduction, and management is hopeful working capital will be kept under check.
- Cash priorities are clear: The first use of cash is to continue doing the current business better; the second is acquisitions, where management is curious about opportunities but wants anything pursued to be accretive to income.
- Dahej facility utilization is set to improve: Actions are expected to significantly improve capacity utilization at the Dahej chemical zone manufacturing facility.
- CFO transition underway: Subhra Gourisaria is moving on for a larger responsibility in another group company.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Long-term EBITDA margin range | Operate in 15% to 20% range; seed at 20%, crop protection at 15% | Over a period of time (no fixed date) |
| Margin improvement ambition | 500 bps steady improvement from prior levels | Long-term, directional |
| Cotton as key contributor | Cotton will remain a significant seed contributor | Next 2 to 3 years |
| Gross margin maintenance | Aim to at least maintain current gross margin levels | Ongoing |
| Working capital discipline | Keep under check via inventory rationalization and tail brand reduction | Ongoing |
| Dahej capacity utilization | Actions expected to significantly improve utilization | No specific timeline |
| New product pipeline | Some products targeted toward next season; paddy and maize mix visible after H1 | End of season / post-H1 |
Key Metrics
| Metric | Q1 FY26 |
|---|---|
| Revenue | ₹957 cr, +20% YoY |
| EBITDA | ₹150 cr, +57% YoY (₹96 cr in Q1 FY25) |
| PAT | ₹95 cr, +98% YoY (₹48 cr in Q1 FY25) |
| Crop Care B2C revenue | ₹449 cr, +13% YoY |
| Crop Care B2B revenue | ₹203 cr, +23% YoY (₹160-165 cr in Q1 FY25); exports up 75% YoY |
| Seed business revenue | ₹305 cr, +38% YoY |
| Seed business volume growth | 20%+ YoY |
| SPH business growth | 33% YoY |
| EBITDA margin long-term target | 15% to 20%, a 500 bps improvement from prior levels |
| Seed business EBITDA margin | ~26% in Q1; long-term target 20% |
| Crop protection long-term EBITDA margin target | 15% |
| Gross margin change | ~200 bps decline vs historical trend, driven by B2B mix and cotton within seeds |
| New products launched (Crop Protection B2C) | 9 products in Q1, including 6 herbicides |
| New products launched (Seeds) | 14 products |
| Diggaz North Cotton packets placed | >0.1 crore packets |
| Cotton share of seed portfolio | >33% |
| Paddy and hybrid maize share of seed portfolio | ~40% combined |
| B2B preceding quarter revenue (Q4 FY25) | ₹182 cr |
| Research rice revenue | ~₹10 cr, up from ~₹5 cr |
| Days on hand | Declined YoY |